Rare diseases
Investigational molecules
Locations
Back to Germany1 786 clinical trials in Berlin, Germany across 17 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Safety and Effectiveness of Pembrolizumab for Patients with Kidney Cancer After Surgery
GermanyStudy of Pembrolizumab as Additional Treatment for Patients with High-Risk Locally Advanced Cutaneous Squamous Cell Carcinoma After Surgery and Radiation
GermanyStudy on Bulevirtide Treatment for Patients with Chronic Hepatitis D
GermanyStudy of LY3819469 for Adults with High Lipoprotein(a) Levels
GermanyStudy of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
GermanyStudy on the Safety and Effectiveness of Stereotactic Body Radiotherapy with or without Pembrolizumab for Patients with Unresected Stage I or II Non-Small Cell Lung Cancer
GermanyStudy on MK-7684A and Docetaxel for Treating Metastatic Non-Small Cell Lung Cancer in Patients After Platinum Chemotherapy and Immunotherapy
GermanyStudy of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer
GermanyStudy on the Safety and Effectiveness of CGT9486 for Patients with Nonadvanced Systemic Mastocytosis
GermanyStudy on Physical Activity and Joint Health in Patients Aged 12 and Older with Severe Hemophilia A Treated with Efanesoctocog Alfa for 24 Months
GermanyStudy on the Effectiveness and Safety of HRO350 for Patients with Mild-to-Moderate Psoriasis
GermanyStudy on Daridorexant for Treating Insomnia in Patients with Insomnia and Nocturia
GermanyThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on various cancer treatments, including studies of metastatic prostate cancer, colorectal cancer, and innovative approaches for breast cancer treatment.
Novel combination therapies and targeted treatments are being evaluated to improve patient outcomes across multiple cancer types.
Comprehensive vaccine development programs targeting various viral infections, including studies on respiratory syncytial virus, cytomegalovirus, and herpes zoster.
These trials aim to enhance immune response and provide long-term protection against serious viral infections.
Innovative treatments for various chronic conditions, including autoimmune dementia, hypertriglyceridemia, and studies in transplant medicine.
Research focuses on developing targeted therapies and improving treatment outcomes for long-term conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
